Encore Orthopedics
You may also be interested in...
Business & Technology Briefs (02/2007)
A short summary of recent market and product developments covering Peripheral Interventions, Cardiovascular and Orthopedic/Spine Surgery, and Oncology.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.